Advertisement
Screener

CAREDX, INC. (CDNA) Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest

CAREDX, INC. Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest

CAREDX, INC. (CDNA) reported Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-24.

Discontinued › Income Statement › Unrealized Gains

us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest · last filed 2021-02-24

  • CAREDX, INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2019-12-31 was $0.00.
  • CAREDX, INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2019-09-30 was $0.00.
  • CAREDX, INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2019-06-30 was $0.00.
  • CAREDX, INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2019-03-31 was $0.00.
  • CAREDX, INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2020 was $0.00.
  • CAREDX, INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2019 was $0.00.
  • CAREDX, INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2018 was -$25.00K.
  • CAREDX, INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2017 was -$99.00K.
Period endComprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 3 monthComprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 6 monthComprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 9 monthComprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 12 month
2020-12-31$0.00
10-K · filed 2021-02-24
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
$0.00
derived: sum of 2 quarters · filed 2021-02-24
$0.00
derived: sum of 3 quarters · filed 2021-02-24
$0.00
10-K · filed 2021-02-24
2019-09-30$0.00
10-Q · filed 2019-10-31
$0.00
derived: sum of 2 quarters · filed 2019-10-31
$0.00
10-Q · filed 2019-10-31
$0.00
derived: sum of 4 quarters · filed 2021-02-24
2019-06-30$0.00
10-Q · filed 2019-08-01
$0.00
10-Q · filed 2019-08-01
$0.00
derived: sum of 3 quarters · filed 2021-02-24
$0.00
derived: sum of 4 quarters · filed 2021-02-24
2019-03-31$0.00
10-Q · filed 2019-05-08
$0.00
derived: sum of 2 quarters · filed 2021-02-24
$0.00
derived: sum of 3 quarters · filed 2021-02-24
$0.00
derived: sum of 4 quarters · filed 2021-02-24
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
$0.00
derived: sum of 2 quarters · filed 2021-02-24
$0.00
derived: sum of 3 quarters · filed 2021-02-24
-$25.00K
10-K · filed 2021-02-24
2018-09-30$0.00
10-Q · filed 2019-10-31
$0.00
derived: sum of 2 quarters · filed 2019-10-31
-$25.00K
10-Q · filed 2019-10-31
$19.00K
derived: sum of 4 quarters · filed 2020-02-28
2018-06-30$0.00
10-Q · filed 2019-08-01
-$25.00K
10-Q · filed 2019-08-01
$19.00K
derived: sum of 3 quarters · filed 2020-02-28
$0.00
derived: sum of 4 quarters · filed 2020-02-28
2018-03-31-$25.00K
10-Q · filed 2019-05-08
$19.00K
derived: sum of 2 quarters · filed 2020-02-28
$0.00
derived: sum of 3 quarters · filed 2020-02-28
-$72.00K
derived: sum of 4 quarters · filed 2020-02-28
2017-12-31$44.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28
$25.00K
derived: sum of 2 quarters · filed 2020-02-28
-$47.00K
derived: sum of 3 quarters · filed 2020-02-28
-$99.00K
10-K · filed 2020-02-28
2017-09-30-$19.00K
10-Q · filed 2018-11-08
-$91.00K
derived: sum of 2 quarters · filed 2018-11-08
-$143.00K
10-Q · filed 2018-11-08
-$440.00K
derived: sum of 4 quarters · filed 2019-03-06
2017-06-30-$72.00K
10-Q · filed 2018-08-09
-$124.00K
10-Q · filed 2018-08-09
-$421.00K
derived: sum of 3 quarters · filed 2019-03-06
-$456.00K
derived: sum of 4 quarters · filed 2019-03-06
2017-03-31-$52.00K
10-Q · filed 2018-05-10
-$349.00K
derived: sum of 2 quarters · filed 2019-03-06
-$384.00K
derived: sum of 3 quarters · filed 2019-03-06
-$407.00K
derived: sum of 4 quarters · filed 2019-03-06
2016-12-31-$297.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06
-$332.00K
derived: sum of 2 quarters · filed 2019-03-06
-$355.00K
derived: sum of 3 quarters · filed 2019-03-06
-$355.00K
10-K · filed 2019-03-06
2016-09-30-$35.00K
10-Q · filed 2017-11-09
-$58.00K
derived: sum of 2 quarters · filed 2017-11-09
-$58.00K
10-Q · filed 2017-11-09
-$58.00K
derived: sum of 4 quarters · filed 2018-03-22
2016-06-30-$23.00K
10-Q · filed 2017-08-11
-$23.00K
10-Q · filed 2017-08-11
-$23.00K
derived: sum of 3 quarters · filed 2018-03-22
-$23.00K
derived: sum of 4 quarters · filed 2018-03-22
2016-03-31$0.00
10-Q · filed 2017-06-09
$0.00
derived: sum of 2 quarters · filed 2018-03-22
$0.00
derived: sum of 3 quarters · filed 2018-03-22
$0.00
derived: sum of 4 quarters · filed 2018-03-22
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22
$0.00
derived: sum of 2 quarters · filed 2018-03-22
$0.00
derived: sum of 3 quarters · filed 2018-03-22
$0.00
10-K · filed 2018-03-22
2015-09-30$0.00
10-Q · filed 2016-11-14
$0.00
derived: sum of 2 quarters · filed 2016-11-14
$0.00
10-Q · filed 2016-11-14
2015-06-30$0.00
10-Q · filed 2016-08-22
$0.00
10-Q · filed 2016-08-22
2014-12-31$0.00
10-K · filed 2017-04-21

Similar stocks

Stock NameCountryMarket CapPE Ratio
Celcuity Inc. (CELC)United States$3.887B-22.62
VERACYTE, INC. (VCYT)United States$3.904B41.21
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
GRAIL, Inc. (GRAL)United States$5.591B-7.78
RadNet, Inc. (RDNT)United States$5.611B-229.65
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
BIODESIX INC (BDSX)United States$0.312B